Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 127, Issue 7, Pages 2492-2504Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI90597
Keywords
-
Categories
Funding
- NIH [RO1AI42819]
Ask authors/readers for more resources
Solid organ transplantation is a curative therapy for hundreds of thousands of patients with end-stage organ failure. However, long-term outcomes have not improved, and nearly half of transplant recipients will lose their allografts by 10 years after transplant. One of the major challenges facing clinical transplantation is antibody-mediated rejection (AMR) caused by anti-donor HLA antibodies. AMR is highly associated with graft loss, but unfortunately there are few efficacious therapies to prevent and reverse AMR. This Review describes the clinical and histological manifestations of AMR, and discusses the immunopathological mechanisms contributing to antibody-mediated allograft injury as well as current and emerging therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available